3DBioFibR Inc., a prominent manufacturer specializing in advanced biopolymer fibers, has announced the successful completion of a $3 million equity financing round. This funding follows a series of recently established paid partnerships and collaborations in vital sectors such as tissue engineering, medical devices, defense, cosmetics, and apparel, involving several multinational corporations.

Source: BusinessWire

A Significant Milestone

This financing marks a crucial milestone for 3DBioFibR, as it enhances operational scale and solidifies its position as a key supplier of next-generation biomaterials.

This investment fuels the next phase of our growth. It enables us to meet growing demand from our commercial partners and to become a qualified supplier for regulated medical and therapeutic applications. ISO 13485 certification is a key step in delivering clinical-grade fibers at the scale and consistency our partners require. We’re excited to expand our impact across industries that urgently need stronger, more sustainable biomaterials.

^{Kevin Sullivan, CEO of 3DBioFibR}

The funds will facilitate:

• Increased manufacturing capacity
• Operational growth
• Implementation of ISO 13485 certification
• Construction of a clean room manufacturing facility, vital for producing medical-grade materials

Expanding Partnerships

In the last two years, 3DBioFibR has secured paid development agreements with a growing list of global and regional companies involved in tissue engineering, medical devices, defense, cosmetics, and apparel. These partnerships aim to incorporate 3DBioFibR’s top-tier fibers into both existing and developing product pipelines. The new investment ensures the company can maintain the delivery of high-performance materials at a commercial scale while also setting the stage for expanded clinical partnerships.

3DBioFibR has accomplished something rare, translating cutting-edge biomaterials science into real commercial traction. They’ve partnered with serious players in global industries and built a manufacturing platform that can deliver fibers at a scale and quality the market hasn’t seen before. This team is setting the benchmark in biopolymer fiber manufacturing, and we’re proud to support their journey.

^{Patrick Keefe, General Partner at Build Ventures}

Innovative Production Capabilities

3DBioFibR's proprietary dry-spinning platform allows for the creation of fibers from a diverse range of biopolymers—over six types—yielding performance metrics that meet or exceed natural tissue strength by two to three times. In contrast to traditional methods like wet spinning and electrospinning, 3DBioFibR's process achieves production at more than 3,600 times the scale, offering significantly improved uniformity and cost-effectiveness. These attributes position the company's fibers for applications where strength, biocompatibility, or scale have previously posed challenges.